Compugen, Inc.
Compugen, Inc., a leading biotechnology company headquartered in California, has been at the forefront of immuno-oncology since its establishment in 1998. With a strong presence in North America and Israel, Compugen focuses on the discovery and development of novel therapeutic agents that harness the immune system to combat cancer. The company is renowned for its innovative approach to drug development, particularly its unique computational biology platform that identifies new immune checkpoints and therapeutic targets. Compugen's core products include monoclonal antibodies and immune-modulating therapies, which have shown promise in clinical trials. Recognised for its significant contributions to the field, Compugen has achieved notable milestones, including strategic partnerships with major pharmaceutical companies, solidifying its position as a key player in the biotechnology industry.
DitchCarbon Score
How does Compugen, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Financial Intermediation industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Compugen, Inc.'s score of 27 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Compugen, Inc.'s reported carbon emissions
In 2022, Compugen, Inc. reported significant carbon emissions, totalling approximately 13,567,000 kg CO2e, all of which fall under Scope 3 emissions. Notably, the company recorded no emissions in Scope 1 and Scope 2 categories, indicating a potential focus on indirect emissions associated with its value chain. Currently, Compugen has not established any specific reduction targets or initiatives, nor does it appear to have made any formal climate pledges. This lack of defined commitments may reflect a broader industry context where many companies are still developing comprehensive strategies to address climate change. As a company headquartered in California, Compugen's emissions profile highlights the importance of addressing Scope 3 emissions, which often represent the largest share of a company's total carbon footprint. Moving forward, it will be crucial for Compugen to consider setting measurable reduction targets to align with global climate goals and enhance its sustainability efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | |
|---|---|
| Scope 1 | - |
| Scope 2 | - |
| Scope 3 | 13,567,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Compugen, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
